DE69109721D1 - Pharmazeutische Zubereitung mit Wirkung auf das Herzgefässsystem, die 3-Methylthiopropionyl L-Carnitin enthält. - Google Patents

Pharmazeutische Zubereitung mit Wirkung auf das Herzgefässsystem, die 3-Methylthiopropionyl L-Carnitin enthält.

Info

Publication number
DE69109721D1
DE69109721D1 DE69109721T DE69109721T DE69109721D1 DE 69109721 D1 DE69109721 D1 DE 69109721D1 DE 69109721 T DE69109721 T DE 69109721T DE 69109721 T DE69109721 T DE 69109721T DE 69109721 D1 DE69109721 D1 DE 69109721D1
Authority
DE
Germany
Prior art keywords
methylthiopropionyl
carnitine
cardiovascular system
effect
pharmaceutical preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69109721T
Other languages
English (en)
Other versions
DE69109721T2 (de
Inventor
Claudio Cavazza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of DE69109721D1 publication Critical patent/DE69109721D1/de
Publication of DE69109721T2 publication Critical patent/DE69109721T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69109721T 1990-03-15 1991-03-11 Pharmazeutische Zubereitung mit Wirkung auf das Herzgefässsystem, die 3-Methylthiopropionyl L-Carnitin enthält. Expired - Fee Related DE69109721T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT47759A IT1240799B (it) 1990-03-15 1990-03-15 Composizioni farmaceutiche contenenti 3-metiltiopropionil l-carnitina ad attivita' sul sistema cardiovascolare.

Publications (2)

Publication Number Publication Date
DE69109721D1 true DE69109721D1 (de) 1995-06-22
DE69109721T2 DE69109721T2 (de) 1995-10-26

Family

ID=11262331

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69109721T Expired - Fee Related DE69109721T2 (de) 1990-03-15 1991-03-11 Pharmazeutische Zubereitung mit Wirkung auf das Herzgefässsystem, die 3-Methylthiopropionyl L-Carnitin enthält.

Country Status (9)

Country Link
US (1) US5173508A (de)
EP (1) EP0448523B1 (de)
JP (1) JPH04217656A (de)
AT (1) ATE122561T1 (de)
DE (1) DE69109721T2 (de)
DK (1) DK0448523T3 (de)
ES (1) ES2072591T3 (de)
HK (1) HK1005565A1 (de)
IT (1) IT1240799B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
IT1263004B (it) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
US5863940A (en) 1997-12-01 1999-01-26 Sigma-Tau Healthscience S.P.A. Medicament and therapeutical method for treating idiopathic asthenozoospermia
PT951909E (pt) 1998-03-19 2004-04-30 Sigma Tau Ind Farmaceuti Composicao combinada que contem uma l-carnitina ou uma alcanoil-l-carnitina um glicosaminoglicano e/ou um seu constituinte

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
IT1116037B (it) * 1979-04-23 1986-02-10 Sigma Tau Ind Farmaceuti Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico
IT1145371B (it) * 1980-05-30 1986-11-05 Sigma Tau Ind Farmaceuti Alcossi-acil carnitine procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
IT1170862B (it) * 1981-03-31 1987-06-03 Sigma Tau Ind Farmaceuti Mercaptoacil-carnitine procedimento per la loro preparazione e loro uso terapeutico
IT1177874B (it) * 1984-07-04 1987-08-26 Sigma Tau Ind Farmaceuti Estere della acetil carnitina,procedimenti per la sua preparazione e composizioni farmaceutiche che lo contengono

Also Published As

Publication number Publication date
IT1240799B (it) 1993-12-17
IT9047759A1 (it) 1991-09-15
US5173508A (en) 1992-12-22
ES2072591T3 (es) 1995-07-16
DE69109721T2 (de) 1995-10-26
ATE122561T1 (de) 1995-06-15
HK1005565A1 (en) 1999-01-15
IT9047759A0 (it) 1990-03-15
JPH04217656A (ja) 1992-08-07
EP0448523B1 (de) 1995-05-17
EP0448523A2 (de) 1991-09-25
DK0448523T3 (da) 1995-06-06
EP0448523A3 (en) 1992-04-15

Similar Documents

Publication Publication Date Title
IE780643L (en) THERAPEUTIC APPLICATION OF d, 1-CARNITINE DERIVITIVES
CA2275225A1 (en) Cardiac lead arrangement
DE69407869D1 (de) Künstliches, in einen Herzventrikel implantiertes Hilfsherz
DE69727190D1 (de) Herzschrittmachersystem mit Glättung der ventrikulären Schrittfrequenz während hoher Vorhofarrythmien
ATE304392T1 (de) Einrichtung zur behandlung von herzarrhythien
IT1238542B (it) Elettrocatetere retrattile tripolare ad ancoraggio endocavitario attivo per la stimolazione cardiaca.
TR200201059T2 (tr) Kardiyak arritmialarının tedavisinde kullanışlı yeni oksabispidin bileşimleri
DE68920545D1 (de) Polyolefinlaminat mit hoher Festigkeit und hohem Elastizitätsmodul, das verbesserte Festkörper-Tiefziehfähigkeit aufweist.
IT9067204A0 (it) Dispositivo per assistenza ventricolare cardiaca, particolarmente per il ricupero della funzione miocardica depressa e per il mantenimento delle funzioni vitali dell'organismo
DE69109721D1 (de) Pharmazeutische Zubereitung mit Wirkung auf das Herzgefässsystem, die 3-Methylthiopropionyl L-Carnitin enthält.
DE3888515D1 (de) Schrittmacher mit im Verteilungssinn anpassbarer Schlagzahl.
DE69110937D1 (de) Herzschrittmacher zur Beendung von Herzarrhythmia.
DE69302544D1 (de) 2-amino-1,2,3,4-tetrahydronaphthalen derivate mit wirkung auf das kardiovasculäre system, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen
IT1275935B1 (it) Derivato di aminotetralina per la terapia di malattie cardiovascolari
DE69007353D1 (de) Landmaschine mit teleskopischen Rotorträgern.
Khan Wolff-Parkinson-White syndrome: pseudo myocardial infarction and pseudo ventricular hypertrophy patterns on electrocardiogram
RU97108900A (ru) Применение этимизола в качестве антиаритмического средства для предупреждения желудочковой экстрасистолии у больных ибс
ES1032802Y (es) Horma perfeccionada aplicable a la conservacion del calzado.
ES2051864T3 (es) Un procedimiento para preparar una composicion farmaceutica con actividad anti-cancer.
ITFI910180A1 (it) Sistema di defibrillazione cardiaca per limitare l'energia erogata al paziente
IT8604931V0 (it) Elettrodo a dipolo per la registrazione e/o la stimilazione cardiaca transesofagea con assunzione per via orale
谷川宗生 Prolonged and fractionated right atrial electrograms during sinus rhythm in patients with paroxysmal atrial fibrillation and sick sinus node syndrome
ITTO911015A0 (it) Dispositivo per assistenza ventricolare cardiaca, particolarmente per il ricupero della funzione miocardica depressa e per il mantenimento delle funzioni vitali dell'organismo.
SU664652A1 (ru) Ортопедическа стелька
IT8821960A0 (it) Struttura di cassetto in alluminio, o simili, provvista di mezzi per la regolazione del frontale.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee